These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 19615288

  • 1. [Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].
    Gu AQ, Han BH, Zhang XY, Shen J, Qi DJ, Xiong LW, Xin Y, Song YY.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):298-301. PubMed ID: 19615288
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
    Li N, Jin ZL, Liu ZJ, Wang J, Li K.
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
    [Abstract] [Full Text] [Related]

  • 3. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
    Liu L, Wang XW, Li L, Zhang X, Zhang WD, Yu XJ.
    Ai Zheng; 2006 Aug; 25(8):990-4. PubMed ID: 16965680
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].
    Gao JF, Zhang XH, Wang J, Rao ZG, Zhu YZ, Ou WL, Zhang BC, Du GZ.
    Ai Zheng; 2005 Aug; 24(8):990-3. PubMed ID: 16086879
    [Abstract] [Full Text] [Related]

  • 5. [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].
    Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, Xia XH, Li DQ.
    Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):134-8. PubMed ID: 18241646
    [Abstract] [Full Text] [Related]

  • 6. [A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].
    Zhang XR, Hou M, Sun JD, Gao JF, Zhu YZ, Peng DW, Zhang YP, Chen J, Yang JL, Liang J, Wang PH, Chu DT.
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):743-6. PubMed ID: 16483488
    [Abstract] [Full Text] [Related]

  • 7. [Vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer previously treated with taxane-based chemotherapy].
    Zhang W, Cao JN, Yin JL, Hong XN, Xu LG.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):587-9. PubMed ID: 14690569
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of chemotherapy-induced leucopenia with treatment outcomes in advanced non-small-cell lung cancer cases receiving the NP regimen.
    Huang CS, Liu L, Liu J, Chen Z, Guo J, Li CZ, Zhou DG, Wang ZH.
    Asian Pac J Cancer Prev; 2012 Nov; 13(9):4481-5. PubMed ID: 23167365
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH, Yu L, Zhang Z, Zhang PJ, Song HP, Guo CY.
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [Abstract] [Full Text] [Related]

  • 12. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
    Chang WJ, Sun JM, Lee JY, Ahn JS, Ahn MJ, Park K.
    Lung Cancer; 2014 Apr 10; 84(1):51-5. PubMed ID: 24521819
    [Abstract] [Full Text] [Related]

  • 19. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
    Belani CP, Fossella F.
    Cancer; 2005 Dec 15; 104(12):2766-74. PubMed ID: 16288485
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.